(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4S,5R,6R)-6-((2S,3R,4S,5S,6R)-3-acetamido-2-((2S,3R,4S,5S,6R)-2-((2R,4R,5R,6R)-5-acetamido-6-(6-azidohexyloxy)-4-hydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylic acid

ID: ALA4591681

Chembl Id: CHEMBL4591681

PubChem CID: 155568475

Max Phase: Preclinical

Molecular Formula: C45H76N6O29

Molecular Weight: 1165.12

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@H]1[C@H](OCCCCCCN=[N+]=[N-])O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@@H](O[C@@H]4O[C@H](CO[C@]5(C(=O)O)C[C@H](O)[C@@H](NC(C)=O)[C@H]([C@H](O)[C@H](O)CO)O5)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@H]2O)[C@@H]1O

Standard InChI:  InChI=1S/C45H76N6O29/c1-16(56)48-25-19(59)10-45(44(69)70,80-38(25)28(61)20(60)11-52)72-15-24-29(62)33(66)34(67)42(76-24)78-37-27(50-18(3)58)41(73-21(12-53)30(37)63)79-39-31(64)22(13-54)74-43(35(39)68)77-36-23(14-55)75-40(26(32(36)65)49-17(2)57)71-9-7-5-4-6-8-47-51-46/h19-43,52-55,59-68H,4-15H2,1-3H3,(H,48,56)(H,49,57)(H,50,58)(H,69,70)/t19-,20+,21+,22+,23+,24+,25+,26+,27+,28+,29-,30+,31-,32+,33-,34+,35+,36+,37-,38+,39-,40+,41-,42-,43-,45+/m0/s1

Standard InChI Key:  KCRARMFQBMRVCB-SVMDDNGNSA-N

Alternative Forms

  1. Parent:

    ALA4591681

    ---

Associated Targets(Human)

CD22 Tclin CD22 (125 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGLEC7 Tchem Sialic acid-binding Ig-like lectin 7 (83 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGLEC9 Tbio Sialic acid-binding Ig-like lectin 9 (9261 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1165.12Molecular Weight (Monoisotopic): 1164.4657AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wu HR, Anwar MT, Fan CY, Low PY, Angata T, Lin CC..  (2019)  Expedient assembly of Oligo-LacNAcs by a sugar nucleotide regeneration system: Finding the role of tandem LacNAc and sialic acid position towards siglec binding.,  180  [PMID:31351394] [10.1016/j.ejmech.2019.07.046]

Source